New York A05852 mandates warning labels on kratom products stating they are not FDA-approved and lists potential side effects, and prohibits labeling.
New York A05852 requires manufacturers of kratom products sold within the state to include a warning label stating that the product has not been approved by the FDA and lists potential side effects. The bill also prohibits labeling these products as "all natural." The warning must be in a font size of at least twelve points and in a color that contrasts with the product's packaging. The law will take effect one year after it becomes effective.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.